Treatment

53 mg/dosis clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingTherapeutic use (Phase IV)
Short-term changes in cardiovascular risk determinants after temporarily stopping gender-affirming hormone therapy in older transgender women - a pilot study
This study looks at health changes in older transgender women who temporarily stop their hormone therapy. Researchers are checking things like blood pressure, cholesterol, and well-being to understand how this break affects their heart health and daily life.
For: Transgender women using long-term gender-affirming hormone therapy
Netherlands